Open- | Close- |
Vol / Avg.0 / 213.327K | Mkt Cap800.244M |
Day Range- - - | 52 Wk Range26.380 - 44.090 |
Fulgent Genetics Stock (NASDAQ: FLGT) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 213.327K | Mkt Cap800.244M |
Day Range- - - | 52 Wk Range26.380 - 44.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | (EXPECTED) 2023-11-06 | |||||
REV | 63.410M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.080 | 0.2500 | ||||
REV | 62.680M | 67.853M | 5.173M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-02 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 50.00 | 45.00 |
2022-12-08 | Piper Sandler | David Westenberg | Downgrades | OverweightNeutral | Lowers | 65.00 | 40.00 |
2022-11-18 | Raymond James | Andrew Cooper | Initiates Coverage On | Outperform | Announces | - | 45.00 |
2022-11-14 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 65.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FLGT | Fulgent Genetics | 0% | 800.2M |
AVAH | Aveanna Healthcare Hldgs | 0% | 226.6M |
CCRN | Cross Country Healthcare | 0% | 887.5M |
AGTI | Agiliti | 0% | 876.5M |
HIMS | Hims & Hers Health | 0% | 1.3B |
You can purchase shares of Fulgent Genetics (NASDAQ: FLGT) through any online brokerage.
Other companies in Fulgent Genetics’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Premier (NASDAQ:PINC).
The latest price target for Fulgent Genetics (NASDAQ: FLGT) was reported by Credit Suisse on Thursday, March 2, 2023. The analyst firm set a price target for 45.00 expecting FLGT to rise to within 12 months (a possible 68.29% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Fulgent Genetics (NASDAQ: FLGT) is $26.74 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Fulgent Genetics.
Fulgent Genetics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Fulgent Genetics.
Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Fulgent Genetics Stock (NASDAQ: FLGT) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 213.327K | Mkt Cap800.244M |
Day Range- - - | 52 Wk Range26.380 - 44.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | (EXPECTED) 2023-11-06 | |||||
REV | 63.410M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.080 | 0.2500 | ||||
REV | 62.680M | 67.853M | 5.173M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-02 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 50.00 | 45.00 |
2022-12-08 | Piper Sandler | David Westenberg | Downgrades | OverweightNeutral | Lowers | 65.00 | 40.00 |
2022-11-18 | Raymond James | Andrew Cooper | Initiates Coverage On | Outperform | Announces | - | 45.00 |
2022-11-14 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 65.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FLGT | Fulgent Genetics | 0% | 800.2M |
AVAH | Aveanna Healthcare Hldgs | 0% | 226.6M |
CCRN | Cross Country Healthcare | 0% | 887.5M |
AGTI | Agiliti | 0% | 876.5M |
HIMS | Hims & Hers Health | 0% | 1.3B |
You can purchase shares of Fulgent Genetics (NASDAQ: FLGT) through any online brokerage.
Other companies in Fulgent Genetics’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Premier (NASDAQ:PINC).
The latest price target for Fulgent Genetics (NASDAQ: FLGT) was reported by Credit Suisse on Thursday, March 2, 2023. The analyst firm set a price target for 45.00 expecting FLGT to rise to within 12 months (a possible 68.29% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Fulgent Genetics (NASDAQ: FLGT) is $26.74 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Fulgent Genetics.
Fulgent Genetics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Fulgent Genetics.
Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Fulgent Genetics Stock (NASDAQ: FLGT) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 213.327K | Mkt Cap800.244M |
Day Range- - - | 52 Wk Range26.380 - 44.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | (EXPECTED) 2023-11-06 | |||||
REV | 63.410M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.080 | 0.2500 | ||||
REV | 62.680M | 67.853M | 5.173M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-02 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 50.00 | 45.00 |
2022-12-08 | Piper Sandler | David Westenberg | Downgrades | OverweightNeutral | Lowers | 65.00 | 40.00 |
2022-11-18 | Raymond James | Andrew Cooper | Initiates Coverage On | Outperform | Announces | - | 45.00 |
2022-11-14 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 65.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FLGT | Fulgent Genetics | 0% | 800.2M |
AVAH | Aveanna Healthcare Hldgs | 0% | 226.6M |
CCRN | Cross Country Healthcare | 0% | 887.5M |
AGTI | Agiliti | 0% | 876.5M |
HIMS | Hims & Hers Health | 0% | 1.3B |
You can purchase shares of Fulgent Genetics (NASDAQ: FLGT) through any online brokerage.
Other companies in Fulgent Genetics’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Premier (NASDAQ:PINC).
The latest price target for Fulgent Genetics (NASDAQ: FLGT) was reported by Credit Suisse on Thursday, March 2, 2023. The analyst firm set a price target for 45.00 expecting FLGT to rise to within 12 months (a possible 68.29% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Fulgent Genetics (NASDAQ: FLGT) is $26.74 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Fulgent Genetics.
Fulgent Genetics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Fulgent Genetics.
Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Fulgent Genetics Stock (NASDAQ: FLGT) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 213.327K | Mkt Cap800.244M |
Day Range- - - | 52 Wk Range26.380 - 44.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | (EXPECTED) 2023-11-06 | |||||
REV | 63.410M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.080 | 0.2500 | ||||
REV | 62.680M | 67.853M | 5.173M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-02 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 50.00 | 45.00 |
2022-12-08 | Piper Sandler | David Westenberg | Downgrades | OverweightNeutral | Lowers | 65.00 | 40.00 |
2022-11-18 | Raymond James | Andrew Cooper | Initiates Coverage On | Outperform | Announces | - | 45.00 |
2022-11-14 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 65.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FLGT | Fulgent Genetics | 0% | 800.2M |
AVAH | Aveanna Healthcare Hldgs | 0% | 226.6M |
CCRN | Cross Country Healthcare | 0% | 887.5M |
AGTI | Agiliti | 0% | 876.5M |
HIMS | Hims & Hers Health | 0% | 1.3B |
You can purchase shares of Fulgent Genetics (NASDAQ: FLGT) through any online brokerage.
Other companies in Fulgent Genetics’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Premier (NASDAQ:PINC).
The latest price target for Fulgent Genetics (NASDAQ: FLGT) was reported by Credit Suisse on Thursday, March 2, 2023. The analyst firm set a price target for 45.00 expecting FLGT to rise to within 12 months (a possible 68.29% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Fulgent Genetics (NASDAQ: FLGT) is $26.74 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Fulgent Genetics.
Fulgent Genetics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Fulgent Genetics.
Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Fulgent Genetics Stock (NASDAQ: FLGT) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 213.327K | Mkt Cap800.244M |
Day Range- - - | 52 Wk Range26.380 - 44.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | (EXPECTED) 2023-11-06 | |||||
REV | 63.410M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.080 | 0.2500 | ||||
REV | 62.680M | 67.853M | 5.173M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-02 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 50.00 | 45.00 |
2022-12-08 | Piper Sandler | David Westenberg | Downgrades | OverweightNeutral | Lowers | 65.00 | 40.00 |
2022-11-18 | Raymond James | Andrew Cooper | Initiates Coverage On | Outperform | Announces | - | 45.00 |
2022-11-14 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 65.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FLGT | Fulgent Genetics | 0% | 800.2M |
AVAH | Aveanna Healthcare Hldgs | 0% | 226.6M |
CCRN | Cross Country Healthcare | 0% | 887.5M |
AGTI | Agiliti | 0% | 876.5M |
HIMS | Hims & Hers Health | 0% | 1.3B |
You can purchase shares of Fulgent Genetics (NASDAQ: FLGT) through any online brokerage.
Other companies in Fulgent Genetics’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Premier (NASDAQ:PINC).
The latest price target for Fulgent Genetics (NASDAQ: FLGT) was reported by Credit Suisse on Thursday, March 2, 2023. The analyst firm set a price target for 45.00 expecting FLGT to rise to within 12 months (a possible 68.29% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Fulgent Genetics (NASDAQ: FLGT) is $26.74 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Fulgent Genetics.
Fulgent Genetics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Fulgent Genetics.
Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Fulgent Genetics Stock (NASDAQ: FLGT) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 213.327K | Mkt Cap800.244M |
Day Range- - - | 52 Wk Range26.380 - 44.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | (EXPECTED) 2023-11-06 | |||||
REV | 63.410M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.080 | 0.2500 | ||||
REV | 62.680M | 67.853M | 5.173M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-02 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 50.00 | 45.00 |
2022-12-08 | Piper Sandler | David Westenberg | Downgrades | OverweightNeutral | Lowers | 65.00 | 40.00 |
2022-11-18 | Raymond James | Andrew Cooper | Initiates Coverage On | Outperform | Announces | - | 45.00 |
2022-11-14 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 65.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FLGT | Fulgent Genetics | 0% | 800.2M |
AVAH | Aveanna Healthcare Hldgs | 0% | 226.6M |
CCRN | Cross Country Healthcare | 0% | 887.5M |
AGTI | Agiliti | 0% | 876.5M |
HIMS | Hims & Hers Health | 0% | 1.3B |
You can purchase shares of Fulgent Genetics (NASDAQ: FLGT) through any online brokerage.
Other companies in Fulgent Genetics’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Premier (NASDAQ:PINC).
The latest price target for Fulgent Genetics (NASDAQ: FLGT) was reported by Credit Suisse on Thursday, March 2, 2023. The analyst firm set a price target for 45.00 expecting FLGT to rise to within 12 months (a possible 68.29% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Fulgent Genetics (NASDAQ: FLGT) is $26.74 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Fulgent Genetics.
Fulgent Genetics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Fulgent Genetics.
Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Fulgent Genetics Stock (NASDAQ: FLGT) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 213.327K | Mkt Cap800.244M |
Day Range- - - | 52 Wk Range26.380 - 44.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | (EXPECTED) 2023-11-06 | |||||
REV | 63.410M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.080 | 0.2500 | ||||
REV | 62.680M | 67.853M | 5.173M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-02 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 50.00 | 45.00 |
2022-12-08 | Piper Sandler | David Westenberg | Downgrades | OverweightNeutral | Lowers | 65.00 | 40.00 |
2022-11-18 | Raymond James | Andrew Cooper | Initiates Coverage On | Outperform | Announces | - | 45.00 |
2022-11-14 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 65.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FLGT | Fulgent Genetics | 0% | 800.2M |
AVAH | Aveanna Healthcare Hldgs | 0% | 226.6M |
CCRN | Cross Country Healthcare | 0% | 887.5M |
AGTI | Agiliti | 0% | 876.5M |
HIMS | Hims & Hers Health | 0% | 1.3B |
You can purchase shares of Fulgent Genetics (NASDAQ: FLGT) through any online brokerage.
Other companies in Fulgent Genetics’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Premier (NASDAQ:PINC).
The latest price target for Fulgent Genetics (NASDAQ: FLGT) was reported by Credit Suisse on Thursday, March 2, 2023. The analyst firm set a price target for 45.00 expecting FLGT to rise to within 12 months (a possible 68.29% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Fulgent Genetics (NASDAQ: FLGT) is $26.74 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Fulgent Genetics.
Fulgent Genetics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Fulgent Genetics.
Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Fulgent Genetics Stock (NASDAQ: FLGT) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 213.327K | Mkt Cap800.244M |
Day Range- - - | 52 Wk Range26.380 - 44.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | (EXPECTED) 2023-11-06 | |||||
REV | 63.410M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.080 | 0.2500 | ||||
REV | 62.680M | 67.853M | 5.173M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-02 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 50.00 | 45.00 |
2022-12-08 | Piper Sandler | David Westenberg | Downgrades | OverweightNeutral | Lowers | 65.00 | 40.00 |
2022-11-18 | Raymond James | Andrew Cooper | Initiates Coverage On | Outperform | Announces | - | 45.00 |
2022-11-14 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 65.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FLGT | Fulgent Genetics | 0% | 800.2M |
AVAH | Aveanna Healthcare Hldgs | 0% | 226.6M |
CCRN | Cross Country Healthcare | 0% | 887.5M |
AGTI | Agiliti | 0% | 876.5M |
HIMS | Hims & Hers Health | 0% | 1.3B |
You can purchase shares of Fulgent Genetics (NASDAQ: FLGT) through any online brokerage.
Other companies in Fulgent Genetics’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Premier (NASDAQ:PINC).
The latest price target for Fulgent Genetics (NASDAQ: FLGT) was reported by Credit Suisse on Thursday, March 2, 2023. The analyst firm set a price target for 45.00 expecting FLGT to rise to within 12 months (a possible 68.29% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Fulgent Genetics (NASDAQ: FLGT) is $26.74 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Fulgent Genetics.
Fulgent Genetics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Fulgent Genetics.
Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Fulgent Genetics Stock (NASDAQ: FLGT) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 213.327K | Mkt Cap800.244M |
Day Range- - - | 52 Wk Range26.380 - 44.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | (EXPECTED) 2023-11-06 | |||||
REV | 63.410M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.080 | 0.2500 | ||||
REV | 62.680M | 67.853M | 5.173M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-02 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 50.00 | 45.00 |
2022-12-08 | Piper Sandler | David Westenberg | Downgrades | OverweightNeutral | Lowers | 65.00 | 40.00 |
2022-11-18 | Raymond James | Andrew Cooper | Initiates Coverage On | Outperform | Announces | - | 45.00 |
2022-11-14 | Credit Suisse | Dan Leonard | Maintains | Outperform | Lowers | 65.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FLGT | Fulgent Genetics | 0% | 800.2M |
AVAH | Aveanna Healthcare Hldgs | 0% | 226.6M |
CCRN | Cross Country Healthcare | 0% | 887.5M |
AGTI | Agiliti | 0% | 876.5M |
HIMS | Hims & Hers Health | 0% | 1.3B |
You can purchase shares of Fulgent Genetics (NASDAQ: FLGT) through any online brokerage.
Other companies in Fulgent Genetics’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Premier (NASDAQ:PINC).
The latest price target for Fulgent Genetics (NASDAQ: FLGT) was reported by Credit Suisse on Thursday, March 2, 2023. The analyst firm set a price target for 45.00 expecting FLGT to rise to within 12 months (a possible 68.29% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Fulgent Genetics (NASDAQ: FLGT) is $26.74 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Fulgent Genetics.
Fulgent Genetics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Fulgent Genetics.
Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.